top of page
Search

Renal Transplant: Immunosuppression & Rejection

TL;DR

Renal Transplant: Immunosuppression & Rejection is a high-yield MRCP Part 1 topic combining immunology, pharmacology, and nephrology. Focus on rejection timelines, mechanisms, and drug toxicities—especially calcineurin inhibitors. Most questions test pattern recognition rather than deep theory. Master the associations and you will secure easy marks.


Why this matters

Renal transplantation is a cornerstone of modern nephrology and a frequently tested topic in MRCP Part 1. It integrates immune mechanisms, drug pharmacology, and clinical reasoning—making it ideal for examiners to test applied knowledge.

Understanding rejection patterns and immunosuppressive strategies is essential not only for exams but also for safe clinical practice. Questions often hinge on timelines, adverse effects, and distinguishing rejection from drug toxicity or infection.

For structured preparation, start with the MRCP Part 1 overview.


Core sections

1. Types of Renal Transplant Rejection (Timeline Framework)

Type

Timing

Mechanism

Key Clinical Clue

Hyperacute

Minutes–hours

Preformed antibodies

Immediate graft failure

Acute

Days–months

T-cell mediated

Rising creatinine

Chronic

Months–years

Fibrosis + vascular damage

Progressive graft loss

Exam focus:

  • Hyperacute → anti-HLA or ABO mismatch

  • Acute → most commonly tested

  • Chronic → irreversible

2. Immunosuppressive Strategy

Transplant immunosuppression is divided into:

Induction therapy (peri-transplant):

  • Basiliximab (IL-2 receptor antagonist)

  • Anti-thymocyte globulin

Maintenance therapy:

  • Calcineurin inhibitors (Tacrolimus, Cyclosporine)

  • Antimetabolites (Mycophenolate, Azathioprine)

  • Corticosteroids

  • mTOR inhibitors (Sirolimus)

3. Calcineurin Inhibitors (Very High Yield)

Mechanism:

  • Inhibit calcineurin → ↓ IL-2 → ↓ T-cell activation

Drugs:

  • Tacrolimus

  • Cyclosporine

Adverse effects (frequently tested):

  • Nephrotoxicity (most important)

  • Hypertension

  • Neurotoxicity (tremor)

  • Hyperglycaemia (tacrolimus)

Cyclosporine-specific:

  • Gum hypertrophy

  • Hirsutism

4. Antimetabolites: Key Differences

Drug

Mechanism

Key Side Effects

Exam Pearl

Mycophenolate

Inhibits purine synthesis

Diarrhoea, cytopenia

Preferred in many regimens

Azathioprine

Converted to 6-MP

Bone marrow suppression

↑ toxicity with allopurinol

Classic MRCP trap: Allopurinol + azathioprine → severe myelosuppression

5. Role of Corticosteroids

  • Used for induction and acute rejection treatment

  • Broad immunosuppressive effects

Side effects:

  • Diabetes mellitus

  • Osteoporosis

  • Increased infection risk

6. Acute Rejection: Recognition & Management

Clinical features:

  • Rising creatinine

  • Reduced urine output

  • Tender graft

Diagnosis:

  • Renal biopsy (gold standard)

Treatment:

  • High-dose corticosteroids

  • Anti-thymocyte globulin (if steroid-resistant)

7. Chronic Rejection

  • Gradual decline in graft function

  • Histology: interstitial fibrosis, vascular narrowing

  • Poor response to treatment

Exam takeaway: Chronic rejection is irreversible—do not choose “steroids” in MCQs.

8. Post-Transplant Infection Risk

Timeframe

Common Infections

0–1 month

Surgical, hospital-acquired

1–6 months

Opportunistic (CMV, Pneumocystis)

>6 months

Community-acquired

9. Malignancy After Transplant

Due to chronic immunosuppression:

  • Skin cancers (most common)

  • Post-transplant lymphoproliferative disorder (PTLD)

10. Monitoring After Transplant

  • Serum creatinine

  • Drug levels (e.g. tacrolimus)

  • Blood pressure

  • Infection surveillance

Medical student studying renal transplant immunosuppression and rejection notes for MRCP Part 1 exam

Practical examples / mini-cases

MCQ Example:

A 50-year-old woman presents 3 weeks after renal transplantation with rising creatinine and graft tenderness.

What is the most likely diagnosis?

A. Hyperacute rejectionB. Acute rejectionC. Chronic rejectionD. Drug toxicityE. Urinary obstruction

Answer: B. Acute rejection

Explanation:

  • Timing (weeks) strongly suggests acute rejection

  • Hyperacute occurs immediately

  • Chronic develops over months–years


Common pitfalls (5 bullets)

  • Confusing rejection timelines (especially acute vs chronic)

  • Missing calcineurin inhibitor nephrotoxicity

  • Forgetting azathioprine–allopurinol interaction

  • Treating chronic rejection as reversible

  • Ignoring infection timing patterns


Study-tip checklist

  • Memorise rejection as a 3-stage timeline

  • Learn drug → side effect pairs (e.g. tacrolimus → nephrotoxicity)

  • Focus on clinical scenarios rather than theory

  • Practise regularly using Free MRCP MCQs

  • Simulate exam pressure with a Start a mock test


FAQs

1. What is the most commonly tested type of rejection in MRCP Part 1?

Acute rejection is the most commonly tested, typically occurring within weeks to months and presenting with rising creatinine.

2. Which immunosuppressant causes nephrotoxicity?

Calcineurin inhibitors (tacrolimus and cyclosporine) are classic causes and frequently appear in exam questions.

3. How is acute rejection confirmed?

Renal biopsy is the gold standard for diagnosis and is required to differentiate from other causes.

4. Why are transplant patients prone to infections?

Immunosuppressive therapy reduces immune defence, increasing susceptibility—especially to opportunistic infections.

5. What is the key exam trap with azathioprine?

Co-administration with allopurinol increases toxicity risk, leading to severe bone marrow suppression.


Ready to start?

Consolidate your understanding with structured revision and targeted practice. Begin with the MRCP Part 1 overview, then reinforce concepts using Free MRCP MCQs and test yourself under exam conditions with a Start a mock test.


Sources

 
 
 

Comments

bottom of page